Search
for
Sort by
Research 301–330 of 1000+
- Hair and scalp disorders
- Periungual lesions secondary to chemotherapy with docetaxel
- Potential Medical Uses of Cannabigerol: A Brief Overview
- Cell Density-Dependent Upregulation of PDCD4 in Keratinocytes and Its Implications for Epidermal Homeostasis and Repair
- Hair shaft miRNA‐221 levels as a new tumor marker of malignant melanoma
- Use of chemotherapy during human pregnancy
- Targeting the Wnt pathways for therapies
- Hair disorders in patients with cancer
- Hair loss in elderly women
- An overview of zinc and its importance in dermatology-Part II: The association of zinc with some dermatologic disorders
- British Hair and Nail Society
- Mucocutaneous reactions to chemotherapy
- Repurposing of approved cardiovascular drugs
- Drug-induced gynecomastia: A systematic review and meta-analysis of randomized clinical trials
- THE GLOBAL CHALLENGE OF CHEMOTHERAPY TOXICITY: RETHINKING SUPPORTIVE CARE IN MODERN ONCOLOGY
- Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
- Lignans and Neolignans: Plant secondary metabolites as a reservoir of biologically active substances
- Synthesis and Structure–Activity Relationships of the First Ferrocenyl-Aryl-Hydantoin Derivatives of the Nonsteroidal Antiandrogen Nilutamide
- Redefining hormone resistance in prostate cancer
- Fatal Toxic Epidermal Necrolysis Associated With Cetuximab in a Patient With Colon Cancer
- Virilizing Adrenocortical Oncocytoma in a Child: A Case Report
- Biochemistry of epidermal stem cells
- Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels
- A comparative analysis of immune privilege in pregnancy and cancer in the context of checkpoint blockade immunotherapy
- The clinical spectrum of parathyroid disease
- Genetic variants in AR and SHBG and resistance to hormonal castration in prostate cancer
- Hyperadrenocorticism in Ferrets
- INCIDENCE OF VIRILISATION IN SEX CORD STROMAL TUMOURS OF OVARY, A 5- YEAR EXPERIENCE IN A TERTIARY CARE GYNAECOLOGICAL CENTRE
- RE: EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER
- Innovative sequence of docetaxel–gemcitabine based on preclinical data in the treatment of advanced non small cell lung cancer: a phase I study